Consolidated Statements of Cash Flows (unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income	$ 17,016	$ 18,655
Adjustments to reconcile net income to cash flows:
Depreciation and amortization	16,631	16,134
Non cash deferred revenue	(9,500)	0
Gain on sale of assets	(4,367)	0
Increase in inventory reserve	2,528	2,430
Allowance for doubtful accounts	509	97
Stock based compensation included in net income	2,006	1,270
Deferred income tax provision	1,185	(1,236)
Equity in losses of partially-owned affiliates	1,657	1,221
Other	262	266
Changes in assets and liabilities:
Trade receivables	(816)	900
Inventories	(31,616)	(8,858)
Prepaid expenses and other current assets	(8,788)	(763)
Accounts payable and other current liabilities	7,438	895
Deferred revenue	(529)	11,433
Other non-current assets and liabilities	5,482	(633)
Discontinued operations:
Net cash used in discontinued operations	(813)	(1,469)
Net cash (used in)/provided by operating activities	(1,715)	40,342
Cash flows from investing activities:
Capital expenditures	(36,353)	(9,062)
Proceeds from sale of assets	1,937	0
Advances to partially-owned affiliates	(941)	(1,321)
Other	(152)	11
Net cash used in investing activities	(35,509)	(10,372)
Long-term debt activity:
Borrowings	57,750	0
Repayments	(20,700)	(30,000)
Proceeds from stock options exercised	1,630	1,072
Other	(302)	(21)
Net cash provided by/(used in) financing activities	38,378	(28,949)
Effect of exchange rate changes on cash and cash equivalents	387	575
Net increase in cash and cash equivalents	1,541	1,596
Cash and cash equivalents at beginning of period	23,551	31,921
Cash and cash equivalents at end of period	$ 25,092	$ 33,517